Global Healthcare Opportunities (GHO) Capital, a London-based healthcare investment firm, has recently netted USD 1.1 Billion to advance European healthcare. The company plans to use the proceeds t...
World Kidney Day World Kidney Day is a global awareness campaign for raising awareness of the importance of our kidneys. 850 MILLION PEOPLE WORLDWIDE are now estimated to have kidney diseases from various causes. Chronic kidney disease (CKD) causes at least 2.4 million deaths per year and is now the 6th fastest ...
Find MoreLet's go an extra mile to spread the word against #HIVAIDS This 30th World AIDS Day, let’s strengthen our efforts to prevent spread of #HIV & #AIDS. Mark your calendars, get yourself tested and know your status! #Prevention is better than #cure, especially when something has No Cure. Have a glance at an infogra...
Find MoreDid you know that Calciphylaxis, or calcific uremic arteriolopathy (CUA), although affects merely 1 to 4 % of patients undergoing dialysis, has a dismal prognosis with up to 80% mortality? In addition to numerous comorbidities which affect the majority of dialysis patients, Calciphylaxis is a painful and often fatal...
Find MoreThe interleukin-33 antibody of AnaptysBio passes midstage test in asthma The pipeline drug, etokimab of AnaptysBio, has positive data in a third indication that adds asthma to one of its triumphs. The US-based company gets another proof-of-concept study for the interleukin-33 (IL-33) inhibitor, because of phase 2a ...
Find MoreFDA still not completely satisfied with Kamada’s inhaled AAT drug(Synthetic Biologics) Kamada is stuck again with a new obstacle in its way to bring the first inhaled treatment for alpha-1 antitrypsin (AAT) deficiency in the market as an alternative to currently present intravenous drugs. The company specializes in ...
Find MoreHyperuricemia is a pathological condition occurring due to excess of uric acid in blood (serum uric acid level > 7.0 mg/dL in adult men and > 5.7 mg/dL in adult women). Hyperuricemia occurs when body either produces too much uric acid or is unable to excrete enough of it. It leads to formation of crystals whi...
Find MoreIonis pharmaceuticals recently licensed-out its antisense drug to AstraZeneca in deal total worth up to USD 330 million Ionis Pharmaceuticals has recently licensed-out an antisense drug to AstraZeneca, bagging a payment of USD 30 million as an upfront licensing fee. AstraZeneca will now be taking care of the develo...
Find MoreTeva looks to sell generics in China through joint venture with Guangzhou Pharma As the world’s largest generics maker, Teva still doesn’t have much of a presence in China, even though it is a country relies heavily on generics. The Israeli company is looking to remedy that as Teva has said it “has no agreement with...
Find MoreInterstitial Cystitis (IC) is a chronic condition that is characterised by recurring pain or discomfort in the bladder and pelvic region. The disease has also been regarded as a precursor for multiple bladder conditions as the symptoms of IC may vary from patient to patient. Thus, the term “Painful Bladder Syndrome”...
Find MoreA chronic pain condition, Complex Regional Pain Syndrome (CRPS) often affects one limb and is believ.....
Find MoreThough Covid-19 has a significant impact on the supply chain, input costs, logistics, and raw materi.....
Find MoreManaging patients virtually, the most important healthcare trend of 2020, is a process where healthc.....
Find MoreHalitosis is an oral health problem caused by volatile molecules which are formed because of patholo.....
Find MoreGastroesophageal Reflux Disease (GERD, also known as chronic acid reflux) is a digestive disorder in.....
Find MoreGout is a chronic disease caused by the deposition of monosodium urate (MSU) crystals in joints. It .....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.